Vaccine Maker Sinovac Rises After Robust 2Q Earnings Report
By Shannon Ellis
Wednesday, August 28, 2013
SHANGHAI – An unexpectedly strong second quarter has boosted investor interest in little-known Sinovac Biotech Ltd., a Beijing-based vaccine maker listed on Nasdaq.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.